P

Inventor

OPPENHEIM AMOS B

IL14 patents
⚠️ This page may combine multiple inventors who share the name “OPPENHEIM AMOS B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BIO TECHNOLOGY GENERAL CORP

12 patents
US5455029AOct 3, 1995

Therapeutic compositions comprising a mixture of human CuZn superoxide dismutase analogs

BIO TECHNOLOGY GENERAL CORP114 citations97
US5457042AOct 10, 1995

Sod polypeptide analogs

BIO TECHNOLOGY GENERAL CORP89 citations95
US5143836ASep 1, 1992

Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda pl promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof

BIO TECHNOLOGY GENERAL CORP93 citations95
US5162217ANov 10, 1992

Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda PL promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof

BIO TECHNOLOGY GENERAL CORP38 citations91
US5147789ASep 15, 1992

Stabilized expression vectors containing lambda pl promoter and the gene for the CI434 repressor, plasmids containing the vectors, hosts containing the plasmids and related methods

BIO TECHNOLOGY GENERAL CORP10 citations71
US5759816AJun 2, 1998

Expression vectors containing λPL promoter and T1 T2 rRNA termination sequence plasmids containing the vectors hosts containing the plasmids and related methods

BIO TECHNOLOGY GENERAL CORP2 citations61
US5126252AJun 30, 1992

Expressions vectors containing Lambda PL promoter and T1 T2 RNA termination sequence, plasmids containing the vectors, hosts containing the plasmids and relatedmethods

BIO TECHNOLOGY GENERAL CORP4 citations60
US5112744AMay 12, 1992

Plasmids for the production of human Cu-Zn superoxide dismutase, bacterial hosts containing the plasmids and methods for production and recovery of such superoxide dismutase

BIO TECHNOLOGY GENERAL CORP3 citations60
US5059529AOct 22, 1991

Stabilized expression vectors containing λPL promoter and the gene for the cI434 repressor, plasmids containing the vectors, hosts containing the plasmids and related methods

BIO TECHNOLOGY GENERAL CORP1 citations60
US5527691AJun 18, 1996

Expression vectors containing lambdapl promoter and T1 T2 rRNA termination sequence, plasmids containing the vectors, hosts containing the plasmids and related methods

BIO TECHNOLOGY GENERAL CORP1 citations51
US5151364ASep 29, 1992

Expression vectors containing lambdapl promoter, T1 T2 RRNA termination sequence, and origin of replication derived from a constitutive high copy number plasmid, and hosts containing the plasmids

BIO TECHNOLOGY GENERAL CORP1 citations50
US5081020AJan 14, 1992

Expression vectors containing λPL promoter, T1 T2 rRNA termination sequence and origin of replication derived from a constitutive high copy number plasmid hosts and related methods

BIO TECHNOLOGY GENERAL CORP0 citations50

YISSUM RES DEV CO

2 patents